1. Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Issue 4 (April 2021) Authors: Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P; Metzner, Bernd; Staiger, Annette M; Horn, Heike; Ott, German; Rosenwa... Journal: Lancet Issue: Volume 8:Issue 4(2021) Page Start: e267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗